Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding-Reference-Cited by-同舟云学术

Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding

Published:2020-05-23 Issue:3 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Sabogal Piñeros Yanaika Shari¹²^ORCID,Dekker Tamara¹²,Smids Barbara¹²,Majoor Christof J.²,Ravanetti Lara¹²,Villetti Gino³,Civelli Maurizio³,Facchinetti Fabrizio³^ORCID,Lutter René¹²

Affiliation:

1. Department of Experimental Immunology Amsterdam Infection & Immunity Institute Amsterdam The Netherlands

2. Department of Respiratory Medicine Amsterdam University Medical Centres University of Amsterdam Amsterdam The Netherlands

3. Corporate Pre‐Clinical R&D Chiesi Farmaceutici S.p.A. Parma Italy

Funder

Chiesi Farmaceutici

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.557

Reference45 articles.

1. Is the prevalence of asthma declining? Systematic review of epidemiological studies

2. Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term Treatment

3. Global asthma prevalence in adults: findings from the cross-sectional world health survey

4. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

5. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease;Frontiers in Pharmacology;2021-11-23